Back to Search Start Over

Trends in cause-specific mortality among persons with Alzheimer's disease in South Carolina: 2014 to 2019.

Authors :
Brown CS
Ning X
Money A
Alford M
Pan Y
Miller M
Lohman M
Source :
Frontiers in aging neuroscience [Front Aging Neurosci] 2024 Apr 17; Vol. 16, pp. 1387082. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Inconsistencies of reports contributes to the underreporting of Alzheimer's disease (AD) on death certificates. Whether underreporting exists within South Carolina has not been studied.<br />Methods: We conducted a prospective, population-based study on a cohort of persons ( N  = 78,534) previously diagnosed with AD and died between 2014-2019. We linked vital records with the South Carolina Alzheimer's Disease and Related Dementias Registry to investigate their cause of death and survival rates. Descriptive analyses calculated frequencies of demographic and health-related characteristics. Turnbull's method estimated the survival probabilities for different subgroups of patients. Hazard ratios were computed from the Cox proportional hazards model, adjusting for the following confounding variables of age at diagnosis, education level, gender, and race.<br />Results: The top immediate cause of death was Alzheimer's disease among all racial groups, except for Native American/American Indian. More females (60.3%) were affected by AD compared to males (39.7%). There is a 25% probability of survival, beyond 5 years, after AD diagnosis. Black/African American AD patients have the smallest risk of all-cause mortality across all racial/ethnic groups (HR 0.87; 95% CI, 0.85-0.89). Individuals with lower education had a lower likelihood of mortality.<br />Conclusion: Although AD was not underreported in the state of South Carolina further research is needed to develop protocols around classification of deaths among those diagnosed with dementia and comorbidities, including cardiovascular disease, to ensure dementia is properly reported as we move to prevent and treat Alzheimer's disease by 2025 and beyond.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Brown, Ning, Money, Alford, Pan, Miller and Lohman.)

Details

Language :
English
ISSN :
1663-4365
Volume :
16
Database :
MEDLINE
Journal :
Frontiers in aging neuroscience
Publication Type :
Academic Journal
Accession number :
38694259
Full Text :
https://doi.org/10.3389/fnagi.2024.1387082